{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:27:25Z","timestamp":1783445245149,"version":"3.54.6"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"7","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2025-0670_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      Thiamine-responsive megaloblastic anemia (TRMA) is a rare but clinically impactful disorder caused by pathogenic\n                      <jats:italic>SLC19A2<\/jats:italic>\n                      variants. Despite its characteristic triad\u00a0\u2013\u00a0megaloblastic anemia, non-autoimmune early-onset diabetes, and sensorineural hearing loss\u00a0\u2013\u00a0TRMA is frequently unrecognized at initial presentation, delaying life-altering treatment. This report highlights how early thiamine therapy can rapidly reverse dysglycemia and hematologic abnormalities, and how diagnostic delay may permit irreversible neurological injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0670_abs_002\">\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Case 1, a six-month-old male, presented with diabetic ketoacidosis and profound anemia. High-dose thiamine produced a striking metabolic response: near-immediate glycemic stabilization, complete insulin discontinuation within days, and normalization of hematologic parameters. Despite optimal early treatment, progressive hearing loss necessitated cochlear implantation. Case 2, a three-year-old male, exhibited recurrent anemia, difficult-to-control diabetes despite insulin therapy, and established sensorineural hearing impairment, following a stroke at age two. Thiamine initiation after delayed genetic confirmation improved dysglycemia and corrected anemia, yet neurological sequelae remained\u00a0fixed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2025-0670_abs_003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These cases underscore TRMA as a high-impact, reversible cause of early-onset diabetes\u00a0\u2013\u00a0but only when recognized promptly. Thiamine can induce complete metabolic remission and insulin independence, offering a therapeutic opportunity unmatched in most pediatric diabetes etiologies. However, once neurological damage develops, metabolic correction alone is insufficient. TRMA should be urgently considered in any child with recurrent macro\/megaloblastic anemia and atypical or antibody-negative diabetes, especially with hearing concerns. Early genetic testing and immediate thiamine therapy are essential to prevent avoidable, lifelong morbidity. In children with unexplained megaloblastic anemia and atypical diabetes, immediate TRMA screening may prevent irreversible complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2025-0670","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:41:31Z","timestamp":1770032491000},"page":"733-740","source":"Crossref","is-referenced-by-count":0,"title":["Childhood thiamine-responsive megaloblastic anemia and diabetes: a case series highlighting early diagnosis and management"],"prefix":"10.1515","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5878-5731","authenticated-orcid":false,"given":"U\u011fur Cem","family":"Y\u0131lmaz","sequence":"first","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetes , 60521 Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Bhriguvanshi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , King George\u2019s Medical University , Lucknow , Uttar Pradesh , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"\u00d6zalp K\u0131z\u0131lay","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetes , 60521 Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samim","family":"\u00d6zen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetes , 60521 Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckran","family":"Darcan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetes , 60521 Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Can","family":"Do\u011fan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Genetics , Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"I\u015f\u0131k","sequence":"additional","affiliation":[{"name":"Department of Pediatric Genetics , Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Karada\u015f","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology , Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie R.","family":"Wood","sequence":"additional","affiliation":[{"name":"University Hospitals Rainbow Babies and Children\u2019s Hospital, Case Western Reserve University , Cleveland , OH , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Libman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology , University of Pittsburgh , Pittsburgh , PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damla","family":"G\u00f6k\u015fen","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology and Diabetes , 60521 Ege University Faculty of Medicine , Izmir , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"2026070716574676996_j_jpem-2025-0670_ref_001","doi-asserted-by":"crossref","unstructured":"Bergmann, AK, Sahai, I, Falcone, JF, Fleming, J, Bagg, A, Borgna-Pignatti, C, et al.. Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update. J\u00a0Pediatr 2009;155:888\u201392.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2009.06.017.","DOI":"10.1016\/j.jpeds.2009.06.017"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_002","doi-asserted-by":"crossref","unstructured":"Labay, V, Raz, T, Baron, D, Mandel, H, Williams, H, Barrett, T, et al.. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat Genet 1999;22:300\u20134. https:\/\/doi.org\/10.1038\/10372.","DOI":"10.1038\/10372"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_003","doi-asserted-by":"crossref","unstructured":"Porter, FS, Rogers, LE, Sidbury, JB. Thiamine-responsive megaloblastic anemia. J\u00a0Pediatr 1969;74:494\u2013504. https:\/\/doi.org\/10.1016\/s0022-3476(69)80031-4.","DOI":"10.1016\/S0022-3476(69)80031-4"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_004","doi-asserted-by":"crossref","unstructured":"Fleming, JC, Tartaglini, E, Steinkamp, MP, Schorderet, DF, Cohen, N, Neufeld, EJ. The gene mutated in thiamine-responsive anaemia with diabetes and deafness encodes a functional thiamine transporter. Nat Genet 1999;22:305\u20138. https:\/\/doi.org\/10.1038\/10379.","DOI":"10.1038\/10379"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_005","doi-asserted-by":"crossref","unstructured":"Abboud, MR, Alexander, D, Najjar, SS. Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. J\u00a0Pediatr 1985;107:537\u201341. https:\/\/doi.org\/10.1016\/s0022-3476(85)80011-1.","DOI":"10.1016\/S0022-3476(85)80011-1"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_006","doi-asserted-by":"crossref","unstructured":"Bouyahia, O, Ouderni, M, Ben Mansour, F, Matoussi, N, Khaldi, F. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia. Ann Endocrinol 2009;70:477\u20139. https:\/\/doi.org\/10.1016\/j.ando.2009.09.001.","DOI":"10.1016\/j.ando.2009.09.001"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_007","doi-asserted-by":"crossref","unstructured":"Haworth, C, Evans, DIK, Mitra, J, Wickramasinghe, SN. Thiamine responsive anaemia: a study of two further cases. Br J Haematol 1982;50:549\u201361. https:\/\/doi.org\/10.1111\/j.1365-2141.1982.tb01955.x.","DOI":"10.1111\/j.1365-2141.1982.tb01955.x"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_008","doi-asserted-by":"crossref","unstructured":"Borgna-Pignatti, C, Marradi, P, Pinelli, L, Monetti, N, Patrini, C. Thiamine-responsive anemia in DIDMOAD syndrome. J\u00a0Pediatr 1989;114:405\u201310. https:\/\/doi.org\/10.1016\/s0022-3476(89)80558-x.","DOI":"10.1016\/S0022-3476(89)80558-X"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_009","doi-asserted-by":"crossref","unstructured":"Shaw-Smith, C, Flanagan, SE, Patch, AM, Grulich-Henn, J, Habeb, AM, Hussain, K, et al.. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. Pediatr Diabetes 2012;13:314\u201321. https:\/\/doi.org\/10.1111\/j.1399-5448.2012.00855.x.","DOI":"10.1111\/j.1399-5448.2012.00855.x"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_010","doi-asserted-by":"crossref","unstructured":"Habeb, AM, Flanagan, SE, Zulali, MA, Abdullah, MA, Pomahacova, R, Boyadzhiev, V, et al.. Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome. Diabetologia 2018;61:1027\u201336. https:\/\/doi.org\/10.1007\/s00125-018-4554-x.","DOI":"10.1007\/s00125-018-4554-x"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_011","doi-asserted-by":"crossref","unstructured":"Valerio, G, Franzese, A, Poggi, V, Tenore, A. Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. Diabetes Care 1998;21:38\u201341. https:\/\/doi.org\/10.2337\/diacare.21.1.38.","DOI":"10.2337\/diacare.21.1.38"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_012","doi-asserted-by":"crossref","unstructured":"Olsen, BS, Hahnemann, JM, Schwartz, M, \u00d8stergaard, E. Thiamine-responsive megaloblastic anaemia: a cause of syndromic diabetes in childhood. Pediatr Diabetes 2007;8:239\u201341. https:\/\/doi.org\/10.1111\/j.1399-5448.2007.00251.x.","DOI":"10.1111\/j.1399-5448.2007.00251.x"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_013","doi-asserted-by":"crossref","unstructured":"Bwititi, P, Wang, L, Butkowski, E, Nwose, EU. Impact of anaemia on HbA1c interpretation among normoglycaemic individuals with diabetes mellitus: a clinical laboratory observational study. Cureus 2023;15:e49901. https:\/\/doi.org\/10.7759\/cureus.49901.","DOI":"10.7759\/cureus.49901"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_014","doi-asserted-by":"crossref","unstructured":"Alzahrani, BA, Salamatullah, HK, Alsharm, FS, Baljoon, JM, Abukhodair, AO, Ahmed, ME, et al.. The effect of different types of anemia on HbA1c levels in non-diabetics. BMC Endocr Disord 2023;23:24. https:\/\/doi.org\/10.1186\/s12902-023-01280-y.","DOI":"10.1186\/s12902-023-01280-y"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_015","doi-asserted-by":"crossref","unstructured":"Aydin, B, Cansu, GB, Ozlu, C. Relationship between glycosylated hemoglobin and vitamin B12 deficiency anemia. North Clin Istanb 2022;9:459\u201363. https:\/\/doi.org\/10.14744\/nci.2022.76259.","DOI":"10.14744\/nci.2022.76259"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_016","doi-asserted-by":"crossref","unstructured":"Villa, V, Rivellese, A, Di Salle, F, Iovine, C, Poggi, V, Capaldo, B. Acute ischemic stroke in a young woman with the thiamine-responsive megaloblastic anemia syndrome. J\u00a0Clin Endocrinol Metab 2000;85:947\u20139. https:\/\/doi.org\/10.1210\/jcem.85.3.6419.","DOI":"10.1210\/jcem.85.3.6419"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_017","doi-asserted-by":"crossref","unstructured":"Mandel, H, Berant, M, Hazani, A, Naveh, Y. Thiamine-dependent beriberi in the thiamine-responsive anemia syndrome. N\u00a0Engl J Med 1984;311:836\u20138. https:\/\/doi.org\/10.1056\/nejm198409273111307.","DOI":"10.1056\/NEJM198409273111307"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_018","doi-asserted-by":"crossref","unstructured":"Diaz, GA, Banikazemi, M, Oishi, K, Desnick, RJ, Gelb, BD. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet 1999;22:309\u201312. https:\/\/doi.org\/10.1038\/10385.","DOI":"10.1038\/10385"},{"key":"2026070716574676996_j_jpem-2025-0670_ref_019","doi-asserted-by":"crossref","unstructured":"Ghaemi, N, Ghahraman, M, Abbaszadegan, MR, Baradaran-Heravi, A, Vakili, R. Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases. J\u00a0Clin Res Pediatr Endocrinol 2013;5:199\u2013201. https:\/\/doi.org\/10.4274\/jcrpe.969.","DOI":"10.4274\/Jcrpe.969"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0670\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0670\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:59:54Z","timestamp":1783443594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2025-0670\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,2,3]]},"published-print":{"date-parts":[[2026,7,24]]}},"alternative-id":["10.1515\/jpem-2025-0670"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2025-0670","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}